TMTomohito Mukaihata

Tomohito Mukaihata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomohito Mukaihata has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bone union‐promoting effect of romosozumab in an ovariectomized rat posterolateral lumbar fusion model

    by Kohei Okuyama, Kazuhide Inage, Geundong Kim, Tomohito Mukaihata, Ikuko Tajiri, Yasuhiro Shiga, Masahiro Inoue, Yawara Eguchi, Miyako Suzuki‐Narita, Takuma Otagiri, et al.

    Spinal fixation surgery has been increasingly performed in patients with osteoporosis. Romosozumab, a drug that was introduced in Japan recently, is known to possibly promote bone healing. However, few studies have reported the therapeutic effects of romosozumab in clinical practice in Japan. Therefore, here, we investigated the effects of romosozumab dosage on bone fusion promotion using an ovariectomized rat spinal fusion model. Eight‐week‐old female Sprague‐Dawley rats were matched by body weight and divided into three groups: 1.0 romosozumab (R) group (Evenity®, 25 mg/kg), 1/10R group (Evenity®, 2.5 mg/kg), and control (C) group (saline). Subcutaneous injections were administered twice a week for 8 weeks postoperatively. Computed tomography scans were performed every 2 weeks from the time of surgery till 8 weeks postoperatively. The mean fusion rates in terms of volume were significantly higher in the R groups [1/10R, 1.0R] than in the C group from 4 weeks postoperatively. The rate of increase was significantly higher in the 1.0R group from 4 weeks postoperatively and in the 1/10R group from 6 weeks postoperatively, than in the C group. The proportion of trabecular bone area was approximately 1.5 times higher in the R groups than in the C group. No significant differences were observed between the R groups. Our results suggest that romosozumab stimulates bone growth at the graft site, and similar effects were achieved at 1/10 of the standard dosage.


  • Quantitative evaluation of the lumbar ligamentum flavum using MRI T2-mapping: Efficacy of its clinical application in patients with lumbar spinal stenosis

    by Hiromitsu Takaoka, Yawara Eguchi, Junya Koroki, Sumihisa Orita, Kazuhide Inage, Yasuhiro Shiga, Takeo Furuya, Satoshi Maki, Masaki Norimoto, Tomotaka Umimura, et al.


  • Differentiating Magnetic Resonance Images of Pyogenic Spondylitis and Spinal Modic Change Using a Convolutional Neural Network

    by Tomohito Mukaihata, Satoshi Maki, Yawara Eguchi, Kim Geundong, Junpei Shoda, Hajime Yokota, Sumihisa Orita, Yasuhiro Shiga, Kazuhide Inage, Takeo Furuya, et al.

    Study Design.: A retrospective analysis of magnetic resonance imaging (MRI). Objective.: The study aimed to evaluate the performance of a convolutional neural network (CNN) to differentiate spinal pyogenic spondylitis from Modic change on MRI. We compared the performance of CNN to that of four clinicians. Summary of Background Data.: Discrimination between pyogenic spondylitis and spinal Modic change is crucial in clinical practice. CNN deep-learning approaches for medical imaging are being increasingly utilized. Methods.: We retrospectively reviewed MRIs from pyogenic spondylitis and spinal Modic change patients. There were 50 patients per group. Sagittal T1-weighted (T1WI), sagittal T2-weighted (T2WI), and short TI inversion recovery (STIR) MRIs were used for CNN training and validation. The deep learning framework Tensorflow was used to construct the CNN architecture. To evaluate CNN performance, we plotted the receiver operating characteristic curve and calculated the area under the curve. We compared the accuracy, sensitivity, and specificity of CNN diagnosis to that of a radiologist, spine surgeon, and two orthopedic surgeons. Results.: The CNN-based area under the curves of the receiver operating characteristic curve from the T1WI, T2WI, and STIR were 0.95, 0.94, and 0.95, respectively. The accuracy of the CNN was significantly greater than that of the four clinicians on T1WI and STIR (PPPPPP<0.05). Conclusion.: We differentiated between Modic changes and pyogenic spondylitis using a CNN that interprets MRI. The performance of the CNN was comparable to, or better than, that of the four clinicians.


  • Open Access

    Bone union and strength effect of Romosozumab: An imaging and mechanical study using a rat posterolateral lumbar fusion model

    by Tomohito Mukaihata, Kazuhide Inage, Yasuhiro Shiga, Geundong Kim, Ikuko Tajiri, Yawara Eguchi, Miyako Suzuki-Narita, Ryuto Tsuchiya, Takuma Otagiri, Takahisa Hishiya, et al.

    In this study, we investigated the effect of romosozumab on bone strength at the fusion site in rats that underwent posterolateral lumbar fusion. For bone grafting, autogenous bone was harvested from the spinous process and grafted between the intervertebral joint and transverse processes of the 4th, 5th, and 6th lumbar vertebra bilaterally along with 40 mg of demineralized bone matrix. Rats were matched by body weight and divided equally into R (romosozumab, 25 mg/kg) and C (control, saline) groups. Subcutaneous injections were administered twice a week until 10 weeks post-operation. Computed tomography was performed 10 weeks post-operation to measure bone fusion rate, fused bone volume, and bone density. The fused area bone strength was also measured using 3-point bending. Results showed that group R rats had significantly higher bone fusion zone volume, bone mineral density, and bone strength than group C rats. Thus, the results demonstrated that romosozumab administration not only promoted osteogenesis at the bone graft site but also affected bone strength. Conclusion We demonstrated that romosozumab administration not only promoted osteogenesis at the bone graft site but also affected bone strength.

  • Bone union‐promoting effect of romosozumab in a rat posterolateral lumbar fusion model

    by Geundong Kim, Kazuhide Inage, Yasuhiro Shiga, Tomohito Mukaihata, Ikuko Tajiri, Yawara Eguchi, Miyako Suzuki‐Narita, Hiromitsu Takaoka, Takashi Hozumi, Norichika Mizuki, et al.

    This study investigated the effect of romosozumab on bone union in a rat posterolateral lumbar fixation model. Posterolateral lumbar fixation was performed on 8‐week‐old male Sprague Dawley rats (n = 20). For bone grafting, autogenous bone (40 mg) was harvested from the spinous processes of the 10th thoracic vertebra until the 2nd lumbar vertebra and implanted between the intervertebral joints and transverse processes of the 4th and 5th lumbar vertebrae on both sides. Rats were matched by body weight and equally divided into two groups: R group (Evenity®, 25 mg/kg) and control (C) group (saline). Subcutaneous injections were administered twice a week until 8 weeks after surgery. Computed tomography was performed at surgery and week 8 after surgery. The area and percentage of bone trabeculae in the total area of bone fusion were calculated. Statistical analysis was performed using an unpaired t test (p < 0.05). We found that the R group rats had significantly higher mean bone union rate and volume than did the C group rats at all time courses starting week 4 after surgery. The R group had significantly higher increase rates than did the C group at weeks 4 and 6 after surgery. The percentage of bone trabeculae area in the R group was approximately 1.7 times larger than that in the C group. Thus, we demonstrated that romosozumab administration has stimulatory effects on bony outgrowth at bone graft sites. We attribute this to the modeling effect of romosozumab.


  • Open Access

    Time-Course Changes in Bone Metabolism Markers and Density in Patients with Osteoporosis Treated with Romosozumab: A Multicenter Retrospective Study

    by Kazuhide Inage, Sumihisa Orita, Yawara Eguchi, Yasuhiro Shiga, Masao Koda, Yasuchika Aoki, Toshiaki Kotani, Tsutomu Akazawa, Takeo Furuya, Junichi Nakamura, et al.

    Inage K, et al. Yonsei Med J. 2021 Sep;62(9):829-835. https://doi.org/10.3349/ymj.2021.62.9.829